Retinoblastoma regression following intra-arterial chemotherapy to the contralateral eye.

Su, Grace L; Lim, Li-Anne S; Welch, R Joel; Shields, Carol L

Su, Grace L; Lim, Li-Anne S; Welch, R Joel; Shields, Carol L.

Afiliação

Su GL; Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, 840 Walnut Street, Suite 1440, Philadelphia, PA 19107, USA.
Lim LS; Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, 840 Walnut Street, Suite 1440, Philadelphia, PA 19107, USA.
Welch RJ; Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, 840 Walnut Street, Suite 1440, Philadelphia, PA 19107, USA.
Shields CL; Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, 840 Walnut Street, Suite 1440, Philadelphia, PA 19107, USA.

Saudi J Ophthalmol ; 33(3): 291-293, 2019.

Article em En | MEDLINE | ID: mdl-31686972

ABSTRACT

ABSTRACT

Intra-arterial chemotherapy (IAC) has assumed a major role in the management of retinoblastoma. This targeted therapy involves the delivery of chemotherapy directly into the ophthalmic artery, minimizing systemic absorption. We report a case of retinoblastoma regression in the untreated eye following IAC to the contralateral eye.

Palavras-chave

Intra-arterial chemotherapy; Optical coherence tomography; Retina; Retinoblastoma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Saudi J Ophthalmol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google